A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio

Valentina Paracchini, Paola Pedotti, Sara Raimondi, Seymour Garte, H. Leon Bradlow, Daniel W. Sepkovic, Emanuela Taioli

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Cytochrome P450 (CYP) is a multigene family of enzymes involved in important life functions; some of these genes are inducible and are implicated in the oxidative metabolic activation and detoxification of many endogenous and exogenous compounds. CYP1B1 codes for an enzyme that catalyses the production of a 2- and 4-hydroxyl group in estrone and estradiol, while CYP1A1 catalyzes the 2-hydroxylation of estradiol in endometrium. The two genes were evaluated in a cohort of 150 subjects: African-American women had significantly lower 2-hydroxyl estrone/16-hydroxyl estrone (2-OHE1/16-OHE1) urinary metabolite ratios than Caucasian women (2.06±1.05 vs. 1.43±0.56; ps0.0002). A common polymorphism in the CYP1B1 gene (leucine to valine at codon 432) was associated with changes in urinary estrogen levels: both Caucasian and African-American women carrying the variant allele showed higher urinary metabolite ratios than women with the wildtype allele. No effect of the CYP1A1 MspI was observed. The 4-OHE1/2-OHE1 ratio was lower in subjects carrying the variant allele (Leu). The percentage change in 2-OHE1/16-OHE1 urinary ratio after indole treatment was significant in both Caucasian and African-American women carrying the wild-type CYP1B1 genotype, although it was more evident in African-Americans than in Caucasians. These results suggest that the Leu /Val CYP1B1 polymorphism may modify estradiol metabolism.

Original languageEnglish
Pages (from-to)702-706
Number of pages5
JournalClinical Chemistry and Laboratory Medicine
Volume43
Issue number7
DOIs
Publication statusPublished - May 16 2005

Fingerprint

Estrone
Polymorphism
Hydroxyl Radical
Estradiol
Cytochrome P-450 CYP1A1
Genes
African Americans
Metabolites
Alleles
Detoxification
Hydroxylation
Valine
Enzymes
Metabolism
Leucine
Cytochrome P-450 Enzyme System
Estrogens
Chemical activation
Multigene Family
Endometrium

Keywords

  • Chemoprevention
  • Epidemiology
  • Estrogen metabolism
  • Transitional study

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio. / Paracchini, Valentina; Pedotti, Paola; Raimondi, Sara; Garte, Seymour; Bradlow, H. Leon; Sepkovic, Daniel W.; Taioli, Emanuela.

In: Clinical Chemistry and Laboratory Medicine, Vol. 43, No. 7, 16.05.2005, p. 702-706.

Research output: Contribution to journalArticle

Paracchini, Valentina ; Pedotti, Paola ; Raimondi, Sara ; Garte, Seymour ; Bradlow, H. Leon ; Sepkovic, Daniel W. ; Taioli, Emanuela. / A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio. In: Clinical Chemistry and Laboratory Medicine. 2005 ; Vol. 43, No. 7. pp. 702-706.
@article{00c083fa859d42a197ff4e4860d9088c,
title = "A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio",
abstract = "Cytochrome P450 (CYP) is a multigene family of enzymes involved in important life functions; some of these genes are inducible and are implicated in the oxidative metabolic activation and detoxification of many endogenous and exogenous compounds. CYP1B1 codes for an enzyme that catalyses the production of a 2- and 4-hydroxyl group in estrone and estradiol, while CYP1A1 catalyzes the 2-hydroxylation of estradiol in endometrium. The two genes were evaluated in a cohort of 150 subjects: African-American women had significantly lower 2-hydroxyl estrone/16-hydroxyl estrone (2-OHE1/16-OHE1) urinary metabolite ratios than Caucasian women (2.06±1.05 vs. 1.43±0.56; ps0.0002). A common polymorphism in the CYP1B1 gene (leucine to valine at codon 432) was associated with changes in urinary estrogen levels: both Caucasian and African-American women carrying the variant allele showed higher urinary metabolite ratios than women with the wildtype allele. No effect of the CYP1A1 MspI was observed. The 4-OHE1/2-OHE1 ratio was lower in subjects carrying the variant allele (Leu). The percentage change in 2-OHE1/16-OHE1 urinary ratio after indole treatment was significant in both Caucasian and African-American women carrying the wild-type CYP1B1 genotype, although it was more evident in African-Americans than in Caucasians. These results suggest that the Leu /Val CYP1B1 polymorphism may modify estradiol metabolism.",
keywords = "Chemoprevention, Epidemiology, Estrogen metabolism, Transitional study",
author = "Valentina Paracchini and Paola Pedotti and Sara Raimondi and Seymour Garte and Bradlow, {H. Leon} and Sepkovic, {Daniel W.} and Emanuela Taioli",
year = "2005",
month = "5",
day = "16",
doi = "10.1515/CCLM.2005.119",
language = "English",
volume = "43",
pages = "702--706",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter GmbH",
number = "7",

}

TY - JOUR

T1 - A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio

AU - Paracchini, Valentina

AU - Pedotti, Paola

AU - Raimondi, Sara

AU - Garte, Seymour

AU - Bradlow, H. Leon

AU - Sepkovic, Daniel W.

AU - Taioli, Emanuela

PY - 2005/5/16

Y1 - 2005/5/16

N2 - Cytochrome P450 (CYP) is a multigene family of enzymes involved in important life functions; some of these genes are inducible and are implicated in the oxidative metabolic activation and detoxification of many endogenous and exogenous compounds. CYP1B1 codes for an enzyme that catalyses the production of a 2- and 4-hydroxyl group in estrone and estradiol, while CYP1A1 catalyzes the 2-hydroxylation of estradiol in endometrium. The two genes were evaluated in a cohort of 150 subjects: African-American women had significantly lower 2-hydroxyl estrone/16-hydroxyl estrone (2-OHE1/16-OHE1) urinary metabolite ratios than Caucasian women (2.06±1.05 vs. 1.43±0.56; ps0.0002). A common polymorphism in the CYP1B1 gene (leucine to valine at codon 432) was associated with changes in urinary estrogen levels: both Caucasian and African-American women carrying the variant allele showed higher urinary metabolite ratios than women with the wildtype allele. No effect of the CYP1A1 MspI was observed. The 4-OHE1/2-OHE1 ratio was lower in subjects carrying the variant allele (Leu). The percentage change in 2-OHE1/16-OHE1 urinary ratio after indole treatment was significant in both Caucasian and African-American women carrying the wild-type CYP1B1 genotype, although it was more evident in African-Americans than in Caucasians. These results suggest that the Leu /Val CYP1B1 polymorphism may modify estradiol metabolism.

AB - Cytochrome P450 (CYP) is a multigene family of enzymes involved in important life functions; some of these genes are inducible and are implicated in the oxidative metabolic activation and detoxification of many endogenous and exogenous compounds. CYP1B1 codes for an enzyme that catalyses the production of a 2- and 4-hydroxyl group in estrone and estradiol, while CYP1A1 catalyzes the 2-hydroxylation of estradiol in endometrium. The two genes were evaluated in a cohort of 150 subjects: African-American women had significantly lower 2-hydroxyl estrone/16-hydroxyl estrone (2-OHE1/16-OHE1) urinary metabolite ratios than Caucasian women (2.06±1.05 vs. 1.43±0.56; ps0.0002). A common polymorphism in the CYP1B1 gene (leucine to valine at codon 432) was associated with changes in urinary estrogen levels: both Caucasian and African-American women carrying the variant allele showed higher urinary metabolite ratios than women with the wildtype allele. No effect of the CYP1A1 MspI was observed. The 4-OHE1/2-OHE1 ratio was lower in subjects carrying the variant allele (Leu). The percentage change in 2-OHE1/16-OHE1 urinary ratio after indole treatment was significant in both Caucasian and African-American women carrying the wild-type CYP1B1 genotype, although it was more evident in African-Americans than in Caucasians. These results suggest that the Leu /Val CYP1B1 polymorphism may modify estradiol metabolism.

KW - Chemoprevention

KW - Epidemiology

KW - Estrogen metabolism

KW - Transitional study

UR - http://www.scopus.com/inward/record.url?scp=26844505026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26844505026&partnerID=8YFLogxK

U2 - 10.1515/CCLM.2005.119

DO - 10.1515/CCLM.2005.119

M3 - Article

C2 - 16207128

AN - SCOPUS:26844505026

VL - 43

SP - 702

EP - 706

JO - Clinical Chemistry and Laboratory Medicine

JF - Clinical Chemistry and Laboratory Medicine

SN - 1434-6621

IS - 7

ER -